Aislinn Antrim

Although challenges and obstacles persist, artificial intelligence could help rural and smaller pharmacies close gaps in care.

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists' value within the health care system. Similarly, the emerging shift toward a standard of care regulatory model holds significant promise for the future of pharmacy practice. By focusing on patient care outcomes and allowing qualified pharmacists to practice to the full extent of their training, this approach can improve access to care and enhance patient safety.

Results suggest that patients commonly receive more than 5 days of treatment, which could be an opportunity for an antimicrobial stewardship initiative.

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

Higher costs of efgartigimod alfa are primarily driven by its status as a newly approved, brand-name therapy without a generic alternative.

Listen Key Takeaways Women with gestational diabetes history have a significantly higher risk of developing type 2 diabetes, especially within 3 to 6 years post-pregnancy.

Vanzacaftor/tezacaftor/deutivacaftor (Alyftek) also received approval for the treatment of cystic fibrosis in people 6 years and older who have at least 1 F508del mutation.

The medication, glepaglutide, is in development for the treatment of adults with short bowel syndrome with intestinal failure who are dependent on parenteral support.

Rates of GBS were similar between Arexvy and Abrysvo, at 0.12% and 0.11% of total reported events, respectively.